Status:
RECRUITING
Acute Myocarditis Registry With Prognostic, Histologic, Immunologic, Biological, Imaging and Clinical Assessment
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Myocarditis
Eligibility:
All Genders
15+ years
Brief Summary
The AMPHIBIA study is an observational ambispective and prospective cohort that aim to describe the histologic, immunologic, biological, imaging, genetic and clinical characteristics of the patients h...
Detailed Description
Acute myocarditis is an inflammatory disease of the heart muscle. Its clinical presentation and its etiologies are multiple and make it a complex disease to treat. Its course also varies, ranging from...
Eligibility Criteria
Inclusion
- Acute myocarditis confirmed by cardiac magnetic resonance according to Lake Louise modified criteria or by endomyocardial biopsy according to histologic, immunologic and immunohistochemic criteria.
- affiliation to the French Health Care System "Sécurité sociale"
Exclusion
- Severe valvulopathy
- Complex congenital cardiopathy
- Previous heart transplant
- Known significative coronary disease
Key Trial Info
Start Date :
January 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2041
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT04844151
Start Date
January 23 2022
End Date
May 1 2041
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Pitié-Salpêtrière
Paris, France, 75013